ID   IF4A3_RAT               Reviewed;         411 AA.
AC   Q3B8Q2;
DT   07-JUL-2009, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2005, sequence version 1.
DT   02-OCT-2024, entry version 131.
DE   RecName: Full=Eukaryotic initiation factor 4A-III;
DE            Short=eIF-4A-III;
DE            Short=eIF4A-III;
DE            EC=3.6.4.13 {ECO:0000250|UniProtKB:P38919};
DE   AltName: Full=ATP-dependent RNA helicase DDX48;
DE   AltName: Full=ATP-dependent RNA helicase eIF4A-3;
DE   AltName: Full=DEAD box protein 48;
DE   AltName: Full=Eukaryotic translation initiation factor 4A isoform 3;
DE   Contains:
DE     RecName: Full=Eukaryotic initiation factor 4A-III, N-terminally processed;
GN   Name=Eif4a3; Synonyms=Ddx48;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17632064; DOI=10.1016/j.cell.2007.05.028;
RA   Giorgi C., Yeo G.W., Stone M.E., Katz D.B., Burge C., Turrigiano G.,
RA   Moore M.J.;
RT   "The EJC factor eIF4AIII modulates synaptic strength and neuronal protein
RT   expression.";
RL   Cell 130:179-191(2007).
CC   -!- FUNCTION: ATP-dependent RNA helicase. Involved in pre-mRNA splicing as
CC       component of the spliceosome. Core component of the splicing-dependent
CC       multiprotein exon junction complex (EJC) deposited at splice junctions
CC       on mRNAs. The EJC is a dynamic structure consisting of core proteins
CC       and several peripheral nuclear and cytoplasmic associated factors that
CC       join the complex only transiently either during EJC assembly or during
CC       subsequent mRNA metabolism. The EJC marks the position of the exon-exon
CC       junction in the mature mRNA for the gene expression machinery and the
CC       core components remain bound to spliced mRNAs throughout all stages of
CC       mRNA metabolism thereby influencing downstream processes including
CC       nuclear mRNA export, subcellular mRNA localization, translation
CC       efficiency and nonsense-mediated mRNA decay (NMD). Its RNA-dependent
CC       ATPase and RNA-helicase activities are induced by CASC3, but abolished
CC       in presence of the MAGOH-RBM8A heterodimer, thereby trapping the ATP-
CC       bound EJC core onto spliced mRNA in a stable conformation. The
CC       inhibition of ATPase activity by the MAGOH-RBM8A heterodimer increases
CC       the RNA-binding affinity of the EJC. Involved in translational
CC       enhancement of spliced mRNAs after formation of the 80S ribosome
CC       complex. Binds spliced mRNA in sequence-independent manner, 20-24
CC       nucleotides upstream of mRNA exon-exon junctions. Shows higher affinity
CC       for single-stranded RNA in an ATP-bound core EJC complex than after the
CC       ATP is hydrolyzed. Involved in the splicing modulation of BCL2L1/Bcl-X
CC       (and probably other apoptotic genes); specifically inhibits formation
CC       of proapoptotic isoforms; the function is different from the
CC       established EJC assembly. Involved in craniofacial development.
CC       {ECO:0000250|UniProtKB:P38919}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC         Evidence={ECO:0000250|UniProtKB:P38919};
CC   -!- ACTIVITY REGULATION: The ATPase activity is increased some 4-fold in
CC       the presence of RNA. {ECO:0000250|UniProtKB:P38919}.
CC   -!- SUBUNIT: Identified in the spliceosome C complex. Core component of the
CC       mRNA splicing-dependent exon junction complex (EJC); the core complex
CC       contains CASC3, EIF4A3, MAGOH or MAGOHB, and RBM8A.
CC       {ECO:0000250|UniProtKB:P38919}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17632064}. Nucleus
CC       speckle {ECO:0000250|UniProtKB:P38919}. Cytoplasm
CC       {ECO:0000269|PubMed:17632064}. Note=Nucleocytoplasmic shuttling
CC       protein. Travels to the cytoplasm as part of the exon junction complex
CC       (EJC) bound to mRNA. Detected in dendritic layer as well as the nuclear
CC       and cytoplasmic (somatic) compartments of neurons. Colocalizes with
CC       STAU1 and FMR1 in dendrites. {ECO:0000269|PubMed:17632064}.
CC   -!- TISSUE SPECIFICITY: Expressed in the CA1 field and dentate gyrus of the
CC       hippocampus (at protein level).
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. eIF4A subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC105875; AAI05876.1; -; mRNA.
DR   EMBL; CH473948; EDM06783.1; -; Genomic_DNA.
DR   RefSeq; NP_001093628.1; NM_001100158.2.
DR   AlphaFoldDB; Q3B8Q2; -.
DR   SMR; Q3B8Q2; -.
DR   BioGRID; 603119; 2.
DR   IntAct; Q3B8Q2; 1.
DR   STRING; 10116.ENSRNOP00000066302; -.
DR   iPTMnet; Q3B8Q2; -.
DR   PhosphoSitePlus; Q3B8Q2; -.
DR   jPOST; Q3B8Q2; -.
DR   PaxDb; 10116-ENSRNOP00000066302; -.
DR   Ensembl; ENSRNOT00000073140.3; ENSRNOP00000066302.1; ENSRNOG00000045791.3.
DR   Ensembl; ENSRNOT00055056649; ENSRNOP00055046755; ENSRNOG00055032767.
DR   Ensembl; ENSRNOT00060046639; ENSRNOP00060038779; ENSRNOG00060026889.
DR   Ensembl; ENSRNOT00065006668; ENSRNOP00065004611; ENSRNOG00065004580.
DR   GeneID; 688288; -.
DR   KEGG; rno:688288; -.
DR   AGR; RGD:1591139; -.
DR   CTD; 9775; -.
DR   RGD; 1591139; Eif4a3.
DR   eggNOG; KOG0328; Eukaryota.
DR   GeneTree; ENSGT00940000155037; -.
DR   HOGENOM; CLU_003041_1_0_1; -.
DR   InParanoid; Q3B8Q2; -.
DR   OMA; KHGANRV; -.
DR   OrthoDB; 1087080at2759; -.
DR   PhylomeDB; Q3B8Q2; -.
DR   Reactome; R-RNO-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-RNO-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-RNO-429947; Deadenylation of mRNA.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-RNO-72187; mRNA 3'-end processing.
DR   Reactome; R-RNO-73856; RNA Polymerase II Transcription Termination.
DR   Reactome; R-RNO-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   PRO; PR:Q3B8Q2; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000234681; Chromosome 10.
DR   Bgee; ENSRNOG00000045791; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0035145; C:exon-exon junction complex; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:RGD.
DR   GO; GO:0071006; C:U2-type catalytic step 1 spliceosome; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0003729; F:mRNA binding; ISO:RGD.
DR   GO; GO:0008143; F:poly(A) binding; ISO:RGD.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IDA:RGD.
DR   GO; GO:0003724; F:RNA helicase activity; ISO:RGD.
DR   GO; GO:0035613; F:RNA stem-loop binding; IDA:RGD.
DR   GO; GO:0035368; F:selenocysteine insertion sequence binding; IDA:RGD.
DR   GO; GO:0008306; P:associative learning; IEP:RGD.
DR   GO; GO:1990416; P:cellular response to brain-derived neurotrophic factor stimulus; IEP:RGD.
DR   GO; GO:0072715; P:cellular response to selenite ion; IEP:RGD.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:UniProtKB.
DR   GO; GO:0035640; P:exploration behavior; IEP:RGD.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0090394; P:negative regulation of excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:RGD.
DR   GO; GO:1904570; P:negative regulation of selenocysteine incorporation; IDA:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:RGD.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; ISO:RGD.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045727; P:positive regulation of translation; ISO:RGD.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:2000622; P:regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; ISO:RGD.
DR   GO; GO:0099578; P:regulation of translation at postsynapse, modulating synaptic transmission; IDA:SynGO.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0006364; P:rRNA processing; IEA:UniProtKB-KW.
DR   CDD; cd18045; DEADc_EIF4AIII_DDX48; 1.
DR   CDD; cd18787; SF2_C_DEAD; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   PANTHER; PTHR47958; ATP-DEPENDENT RNA HELICASE DBP3; 1.
DR   PANTHER; PTHR47958:SF26; EUKARYOTIC INITIATION FACTOR 4A-III; 1.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cytoplasm; Helicase; Hydrolase; Isopeptide bond;
KW   mRNA processing; mRNA splicing; mRNA transport;
KW   Nonsense-mediated mRNA decay; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding; rRNA processing; Spliceosome;
KW   Translation regulation; Transport; Ubl conjugation.
FT   CHAIN           1..411
FT                   /note="Eukaryotic initiation factor 4A-III"
FT                   /id="PRO_0000423271"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   CHAIN           2..411
FT                   /note="Eukaryotic initiation factor 4A-III, N-terminally
FT                   processed"
FT                   /id="PRO_0000378555"
FT   DOMAIN          69..239
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          250..411
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   MOTIF           38..66
FT                   /note="Q motif"
FT   MOTIF           187..190
FT                   /note="DEAD box"
FT                   /evidence="ECO:0000305"
FT   BINDING         60
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   BINDING         65
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   BINDING         85..90
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   BINDING         342
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   BINDING         367..371
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   MOD_RES         2
FT                   /note="N-acetylalanine; in Eukaryotic initiation factor 4A-
FT                   III, N-terminally processed"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P60842"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   MOD_RES         124
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P60842"
FT   MOD_RES         163
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   MOD_RES         198
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P60843"
FT   MOD_RES         296
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   MOD_RES         321
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   CROSSLNK        19
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   CROSSLNK        152
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P60842"
FT   CROSSLNK        314
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
FT   CROSSLNK        374
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P60842"
FT   CROSSLNK        382
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P38919"
SQ   SEQUENCE   411 AA;  46841 MW;  987DAF10824DEC4D CRC64;
     MAATATMATS GSARKRLLKE EDMTKVEFET SEEVDVTPTF DTMGLREDLL RGIYAYGFEK
     PSAIQQRAIK QIIKGRDVIA QSQSGTGKTA TFSISVLQCL DIQVRETQAL ILAPTRELAV
     QIQKGLLALG DYMNVQCHAC IGGTNVGEDI RKLDYGQHVV AGTPGRVFDM IRRRSLRTRA
     IKMLVLDEAD EMLNKGFKEQ IYDVYRYLPP ATQVVLISAT LPHEILEMTN KFMTDPIRIL
     VKRDELTLEG IKQFFVAVER EEWKFDTLCD LYDTLTITQA VIFCNTKRKV DWLTEKMREA
     NFTVSSMHGD MPQKERESIM KEFRSGASRV LISTDVWARG LDVPQVSLII NYDLPNNREL
     YIHRIGRSGR YGRKGVAINF VKNDDIRILR DIEQYYSTQI DEMPMNVADL I
//
